title: Electronic Health Record Availability and Anxiety Treatment in Office-Based Practices.
abstract: This study compared the probability of receiving anxiety treatment during a physician visit to primary care practices with and without an electronic health record (EHR).
  
  
  
  The 2007-2010 National Ambulatory Medical Care Survey was used to identify visits for anxiety (N=290). The outcome was receipt of anxiety treatment. The independent variable was the presence of a fully functioning EHR. Logistic regression was used to conduct the analysis.
  
  
  
  Patients who were seen in practices with a fully functioning EHR had lower odds of being offered antianxiety medication (adjusted odds ratio [AOR]=.37, 95% confidence interval [CI]=.15-.90, p=.028), mental health counseling (AOR=.43, CI=.18-1.04, p=.061), and any anxiety treatment (AOR=.40, CI=.15-1.05, p=.062) compared with patients at practices without a fully functioning EHR.
  
  
  
  EHRs may have a negative impact on the delivery of care for anxiety during primary care visits. Future studies should monitor the impact of EHRs on delivery and quality of care.
authors.affiliation: Dr. Harman is with the Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee. Mr. Mills is with the Department of Health Services Research, Management and Policy, and Dr. Cook is with the Department of Epidemiology and Medicine, University of Florida, Gainesville. Dr. Harle is with the Department of Health Policy and Management, Indiana University, Indianapolis. Send correspondence to Mr. Mills (e-mail: joncmills@ufl.edu ).
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Harman
authors.affiliation: Dr. Harman is with the Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee. Mr. Mills is with the Department of Health Services Research, Management and Policy, and Dr. Cook is with the Department of Epidemiology and Medicine, University of Florida, Gainesville. Dr. Harle is with the Department of Health Policy and Management, Indiana University, Indianapolis. Send correspondence to Mr. Mills (e-mail: joncmills@ufl.edu ).
authors.forename: Jon
authors.initials: J
authors.lastname: Mills
authors.affiliation: Dr. Harman is with the Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee. Mr. Mills is with the Department of Health Services Research, Management and Policy, and Dr. Cook is with the Department of Epidemiology and Medicine, University of Florida, Gainesville. Dr. Harle is with the Department of Health Policy and Management, Indiana University, Indianapolis. Send correspondence to Mr. Mills (e-mail: joncmills@ufl.edu ).
authors.forename: Robert L
authors.initials: RL
authors.lastname: Cook
authors.affiliation: Dr. Harman is with the Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee. Mr. Mills is with the Department of Health Services Research, Management and Policy, and Dr. Cook is with the Department of Epidemiology and Medicine, University of Florida, Gainesville. Dr. Harle is with the Department of Health Policy and Management, Indiana University, Indianapolis. Send correspondence to Mr. Mills (e-mail: joncmills@ufl.edu ).
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Harle
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy / Q000628:therapy*; D003695:Delivery of Health Care / Q000706:statistics & numerical data*; D057286:Electronic Health Records / Q000706:statistics & numerical data*; D019538:Health Care Surveys / Q000706:statistics & numerical data; D006801:Humans; D011320:Primary Health Care / Q000706:statistics & numerical data*
chemical_list: D014151:Anti-Anxiety Agents